CNS Therapeutics (Old)

CNS Therapeutics, located in St. Paul, Minnesota, is a private company focused on developing and marketing pharmaceuticals designed for targeted delivery to the central nervous system. The company aims to address neurological disorders and chronic pain through innovative treatments. Its first product, Gablofen, has received FDA approval and is used for intrathecal baclofen therapy. CNS Therapeutics is also engaged in collaborations with both U.S. and international experts to create and evaluate new therapeutic options for conditions such as pain and Parkinson's disease.